Although PIK75 and BGT226 are PI3K inhibitors that target the catalytic p110α subunit of PI3K, the mechanism of ACC cell death when combined with STA9090 demonstrated differences. This evidence concerns the gene PIK3CG and adrenal cortex carcinoma.